Literature DB >> 17787036

Design of recombinant antibody microarrays for complex proteome analysis: choice of sample labeling-tag and solid support.

Christer Wingren1, Johan Ingvarsson, Linda Dexlin, Dominika Szul, Carl A K Borrebaeck.   

Abstract

Antibody-based microarray is a novel technology with great potential within high-throughput proteomics. The process of designing high-performing antibody (protein) microarrays has, however, turned out to be a challenging process. In this study, we have developed further our human recombinant single-chain variable-fragment (scFv) antibody microarray methodology by addressing two crucial technological issues, choice of sample labeling-tag and solid support. We examined the performance of a range of dyes in a one- or two-color approach on a selection of solid supports providing different surface and coupling chemistries, and surface structures. The set-ups were evaluated in terms of sensitivity, specificity, and selectivity. The results showed that a one-color approach, based on NHS-biotin (or ULS-biotin) labeling, on black polymer Maxisorb slides (or Nexterion slide H) was the superior approach for targeting low-abundant (pg/mL) analytes in nonfractionated, complex proteomes, such as human serum or crude cell supernatants. Notably, microarrays displaying adequate spot morphologies, high S/Ns, minimized nonspecific binding, and most importantly a high selectivity, specificity, and sensitivity (>or=fM range) were obtained. Taken together, we have designed the first generation of a high-performing recombinant scFv antibody microarray technology platform on black polymer Maxisorb slides for sensitive profiling of low-abundant analytes in nonfractionated biotinylated complex proteomes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17787036     DOI: 10.1002/pmic.200700025

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  22 in total

1.  Proteomics-based dissection of human endoderm progenitors by differential cell capture on antibody array.

Authors:  Revital Sharivkin; Michael D Walker; Yoav Soen
Journal:  Mol Cell Proteomics       Date:  2012-05-10       Impact factor: 5.911

Review 2.  New technologies in cancer. Protein microarrays for biomarker discovery.

Authors:  Sergio Matarraz; María González-González; María Jara; Alberto Orfao; Manuel Fuentes
Journal:  Clin Transl Oncol       Date:  2011-03       Impact factor: 3.405

3.  Applications of protein microarrays for biomarker discovery.

Authors:  Niroshan Ramachandran; Sanjeeva Srivastava; Joshua Labaer
Journal:  Proteomics Clin Appl       Date:  2008-09-10       Impact factor: 3.494

4.  Molecular serum portraits in patients with primary breast cancer predict the development of distant metastases.

Authors:  Anders Carlsson; Christer Wingren; Malin Kristensson; Carsten Rose; Mårten Fernö; Håkan Olsson; Helena Jernström; Sara Ek; Elin Gustavsson; Christian Ingvar; Mattias Ohlsson; Carsten Peterson; Carl A K Borrebaeck
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-15       Impact factor: 11.205

5.  Plasma protein profiling in a stage defined pancreatic cancer cohort - Implications for early diagnosis.

Authors:  Anna Sandström Gerdtsson; Christer Wingren; Helena Persson; Payam Delfani; Malin Nordström; He Ren; Xin Wen; Ulrika Ringdahl; Carl A K Borrebaeck; Jihui Hao
Journal:  Mol Oncol       Date:  2016-07-12       Impact factor: 6.603

6.  Dual-color proteomic profiling of complex samples with a microarray of 810 cancer-related antibodies.

Authors:  Christoph Schröder; Anette Jacob; Sarah Tonack; Tomasz P Radon; Martin Sill; Manuela Zucknick; Sven Rüffer; Eithne Costello; John P Neoptolemos; Tatjana Crnogorac-Jurcevic; Andrea Bauer; Kurt Fellenberg; Jörg D Hoheisel
Journal:  Mol Cell Proteomics       Date:  2010-02-16       Impact factor: 5.911

7.  Oncoproteomic profiling with antibody microarrays.

Authors:  Mohamed Ss Alhamdani; Christoph Schröder; Jörg D Hoheisel
Journal:  Genome Med       Date:  2009-07-06       Impact factor: 11.117

8.  Serum protein profiling of systemic lupus erythematosus and systemic sclerosis using recombinant antibody microarrays.

Authors:  Anders Carlsson; Dirk M Wuttge; Johan Ingvarsson; Anders A Bengtsson; Gunnar Sturfelt; Carl A K Borrebaeck; Christer Wingren
Journal:  Mol Cell Proteomics       Date:  2011-02-24       Impact factor: 5.911

9.  Identification of plasma protein profiles associated with risk groups of prostate cancer patients.

Authors:  Malin Nordström; Christer Wingren; Carsten Rose; Anders Bjartell; Charlotte Becker; Hans Lilja; Carl A K Borrebaeck
Journal:  Proteomics Clin Appl       Date:  2014-10-22       Impact factor: 3.494

10.  Development of reverse phase protein microarrays for the validation of clusterin, a mid-abundant blood biomarker.

Authors:  Adriana Aguilar-Mahecha; Christiane Cantin; Maureen O'Connor-McCourt; Andre Nantel; Mark Basik
Journal:  Proteome Sci       Date:  2009-04-06       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.